-
1
-
-
0029092369
-
Doxifluridine and leucovorin: An oral treatment combination in advanced colorectal cancer
-
Bajetta E., Colleoni M., Di Bartolomeo M., Buzzoni R., Bozzetti F., Doci R., Somma L., Cappuzzo F., Gallo Stampino C., Guenzi A., Balant L.P., Zilembo N., Di Leo A.: Doxifluridine and leucovorin: an oral treatment combination in advanced colorectal cancer. J. Clin. Oncol., 13: 2613-2619, 1995.
-
(1995)
J. Clin. Oncol.
, vol.13
, pp. 2613-2619
-
-
Bajetta, E.1
Colleoni, M.2
Di Bartolomeo, M.3
Buzzoni, R.4
Bozzetti, F.5
Doci, R.6
Somma, L.7
Cappuzzo, F.8
Gallo Stampino, C.9
Guenzi, A.10
Balant, L.P.11
Zilembo, N.12
Di Leo, A.13
-
2
-
-
0027161283
-
Prospective randomized trial comparing fluorouracil versus doxifluridine for the treatment of advanced colorectal cancer
-
Bajetta E., Colleoni M., Rosso R., Sobrero A., Amadori D., Comella G., Marangolo M., Scanni A., Lorusso V., Calabresi F., Bonsignori M., Crivellari A., Pasquini E., Bruzzi P., Repetto M., Criscuolo D.: Prospective randomized trial comparing fluorouracil versus doxifluridine for the treatment of advanced colorectal cancer. Eur. J. Cancer, 29A (12): 1658-1663, 1993.
-
(1993)
Eur. J. Cancer
, vol.29 A
, Issue.12
, pp. 1658-1663
-
-
Bajetta, E.1
Colleoni, M.2
Rosso, R.3
Sobrero, A.4
Amadori, D.5
Comella, G.6
Marangolo, M.7
Scanni, A.8
Lorusso, V.9
Calabresi, F.10
Bonsignori, M.11
Crivellari, A.12
Pasquini, E.13
Bruzzi, P.14
Repetto, M.15
Criscuolo, D.16
-
3
-
-
0002138318
-
Antimetabolites
-
De Vita V.T. Jr., Hellman S., Rosenberg S.A. (Eds.), Lippincott, Philadelphia
-
Chu E., Takimoto C.H. Antimetabolites. In: Cancer, principles and practice of oncology, 4th edn., De Vita V.T. Jr., Hellman S., Rosenberg S.A. (Eds.), pp. 362-365, Lippincott, Philadelphia, 1993.
-
(1993)
Cancer, Principles and Practice of Oncology, 4th Edn.
, pp. 362-365
-
-
Chu, E.1
Takimoto, C.H.2
-
4
-
-
0001560702
-
Capecitabine: An orally evaluable fluoropyrimidine with tumor selective activity
-
Abst 2426
-
Ishitsuka H., Miwa M., Ishitsuka T., Ura M., Sawada N., Nishida M., Fukase Y., Yamamoto T., Mori K., Arasaki M., Umeda I., Shimma N.: Capecitabine: an orally evaluable fluoropyrimidine with tumor selective activity (Abst 2426). Proc. Am. Assoc. Cancer Res., 36: 407, 1995.
-
(1995)
Proc. Am. Assoc. Cancer Res.
, vol.36
, pp. 407
-
-
Ishitsuka, H.1
Miwa, M.2
Ishitsuka, T.3
Ura, M.4
Sawada, N.5
Nishida, M.6
Fukase, Y.7
Yamamoto, T.8
Mori, K.9
Arasaki, M.10
Umeda, I.11
Shimma, N.12
-
5
-
-
0024367458
-
Phase I-II trial of doxifluridine (5′-DFUR) administered as long term continuous infusion using a portable infusion pump for advanced colorectal cancer
-
Schuster D., Heim M.E.: Phase I-II trial of doxifluridine (5′-DFUR) administered as long term continuous infusion using a portable infusion pump for advanced colorectal cancer. Eur. Cancer Clin. Oncol., 25: 1543-1548, 1989.
-
(1989)
Eur. Cancer Clin. Oncol.
, vol.25
, pp. 1543-1548
-
-
Schuster, D.1
Heim, M.E.2
-
6
-
-
0001770154
-
Appendix a grading of toxicity
-
Lippincott, Philadelphia
-
Appendix A grading of toxicity. In: Manual of oncologic therapeutics, Wittes R.E. (Ed.), pp. 445-448, Lippincott, Philadelphia, 1991.
-
(1991)
Manual of Oncologic Therapeutics
, pp. 445-448
-
-
Wittes, R.E.1
|